The forum addressed supply chain concerns, challenges and opportunities going forward in a post-Covid world, with 16 industry associations across the globe in participation remotely.

•Global neovascular AMD market, estimated at $6.9 billion in 2018, is projected to reach $10.4 billion by 2024, registering a CAGR of 7.1% during the forecast period.
•Eye drop provides alternative self-care treatment for AMD patients compared to intravitreal(IVT) injection of VEGF antibodies by ophthalmologists.

This delivery system may offer significant advantages for the use of platinum medicines in the management of locally advanced cancers, treating microscopic lymph node disease with better efficacy than current high-dose systemic chemotherapy. Currently, we have generated a drug candidate (CPHC008) and processed the pilot scale up.

The common practice of RFA is to percutaneously inject an electrode to a target lesion guided by medical images and to generate an RF current with oscillation frequency between 350 and 500kHz. The RF waves agitate tissue ions around the electrode and result in temperature increase within the tissue due to frictional heat which causes local tissue necrosis for lesion treatments.

Bugu-S™is a natural product from multiple plant extracts with raw materials registered in the "Full List of Raw Materials Available for Food" of the Ministry of Health and Welfare in Taiwan. Manufacturing and quality comply with domestic ISO22000 and HACCP food hygiene management regulations. Animal and human studies have shown that Bugu-S™ could promote sleep, as well as improve insomnia and its derived physical stress and tension.

The 3D endoscope developed by ITRI can provide real 3D images without increasing the diameter of the endoscope, and help doctors to operate the surgery more easily. It is expected to extend the usage of 3D imagesin endoscopy. The 3D endoscope imaging module includes a main lens, a microlens arrays, a sensor and image processing software. After processing the image captured by the module, it can be output to a 3D display and converted into a stereoscopic image.

The first kit for detection Kawasaki Disease by microRNA to help diagnosis making and disease treatment precisely.

The first kit of optical detection system can identify the severity of fever and Kawasaki disease in just one second by AI analysis. Every home will need it as convenient as the body temperature thermometer usage at home.

The first kit of antibody profiling to detect Kawasaki Disease with only one drop of blood to make diagnosis. It took only 125 pl of plasma (means only 1/1,000,000 ml of blood extraction was needed for identify KD and controls by this innovation.